Saltar al contenido
Merck

Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic pain.

Bioorganic & medicinal chemistry letters (2009-08-18)
Pengcheng P Shao, Feng Ye, Ann E Weber, Xiaohua Li, Kathryn A Lyons, William H Parsons, Maria L Garcia, Birgit T Priest, McHardy M Smith, John P Felix, Brande S Williams, Gregory J Kaczorowski, Erin McGowan, Catherine Abbadie, William J Martin, Daniel R McMasters, Ying-Duo Gao
RESUMEN

A series of novel isoxazole voltage gated sodium channel blockers have been synthesized and evaluated. Substitutions on the benzylic position of benzamide were investigated to determine their effect on Na(v)1.7 inhibitory potency. The spirocyclobutyl substitution had the most significant enhancement on Na(v)1.7 inhibitory activity.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
1-Cyclopentenecarboxylic acid, 98%